Back to top

Aetna Inc. (AET)

(Real Time Quote from BATS)

$201.86 USD


+0.23 (0.11%)

Updated Sep 26, 2018 10:40 AM ET

Add to portfolio

3-Hold     3    

C Value | D Growth | A Momentum | C VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

View All Zacks #1 Ranked Stocks

Trades from $1

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.67%
2 Buy 18.52%
3 Hold 10.06%
4 Sell 5.47%
5 Strong Sell 2.34%
S&P 500 10.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Zacks News

Zacks Equity Research

Aetna Inks Deals to Improve Patient Care in Philadelphia

Aetna (AET) collaborates with Oak Street Health and ChenMed for enhancing the experience of its Medicare members in the Philadelphia market.


Zacks Equity Research

Cigna Moves Closer to Express Scripts Buyout With DoJ Nod

Cigna (CI) clears a significant regulatory hurdle with regards to its proposed acquisition of Express Scripts.


Zacks Equity Research

Abbott's DRG Therapy Now Covered by Aetna, To Boost Uptake

Abbott (ABT) to see a rise in customer adoption of its DRG therapy following the receipt of new national coverage from Aetna.


Zacks Equity Research

Molina Healthcare Surges 80% YTD: Can the Rally Continue?

Molina Healthcare (MOH) gains from its rebounding endeavors and a niche positioning in the Medicaid market.


Zacks Equity Research

Anthem Ties Up With Walmart to Better Serve Medicare Members

Anthem (ANTM) teams up with Walmart to provide medical supplies across its counter.


Zacks Equity Research

Pharmacies and Drug Stores Stock Outlook: Prospects Bright

Amazon's entry into drug distribution is expected be a game changer but the immediate implications will be limited, given that the healthcare space is highly complex and regulated.


Zacks Equity Research

Aetna (AET) Reaches 52-Week High on a Solid Second Quarter

Aetna's (AET) shares scale a 52-week high on Aug 17, 2018 led by strong second-quarter performance.


Zacks Equity Research

Aetna Launches Scheme for Better Patient Care Amenities

Aetna (AET) proposes a new regional plan to serve employers better.


Zacks Equity Research

UnitedHealth to Spread in Pharmacy Business With Genoa Deal

UnitedHealth's (UNH) acquisition of Genoa Health should aid the company's Optum segment.


Zacks Equity Research

Molina Healthcare Hits 52-Week High: Is Further Upside Left?

Molina Healthcare (MOH) stock gains as its restructuring initiatives start bearing fruit.


Zacks Equity Research

Envision Healthcare (EVHC) Q2 Earnings Beat, Revenues Miss

Envision Healthcare (EVHC) Q2 earnings were backed by higher contribution from its segments.


Sheraz Mian

Q2 Scorecard & Research Reports for Gilead, American Tower & Others

Today's Research Daily features new research reports on 16 major stocks, including Gilead (GILD), American Tower (AMT) and Chubb (CB).


Zacks Equity Research

Aetna (AET) Q2 Earnings Beat Estimates, Membership Declines

Aetna's (AET) Q2 earnings gained from a lower tax rate partly offset by increase in expenses.


Zacks Equity Research

Aetna (AET) Q2 Earnings and Revenues Beat Estimates

Aetna (AET) delivered earnings and revenue surprises of 11.73% and 0.83%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?


Zacks Equity Research

Will a Decline in Membership Mar Aetna's (AET) Q2 Earnings?

Aetna (AET) Q2 earnings to suffer from lower membership and revenues partly offset by a lower tax rate.


Zacks Equity Research

How Will Membership Affect UnitedHealth's (UNH) Q2 Earnings?

UnitedHealth (UNH) should see an increase in Public Group and International business, partially offset by lower commercial membership.


Zacks Equity Research

UnitedHealth's Unit to Provide Better Care in North Carolina

UnitedHealth's (UNH) arm forges an alliance with Community Care for providing better and cost-efficient care in North Carolina.


Zacks Equity Research

4 Reasons That Make WellCare Health Plans an Attractive Pick

WellCare Health Plans (WCG) looks attractive given its promising growth prospects.


Sapna Bagaria

Will Insurers Suffer on Halt in Risk-Adjustment Payment?

The most-recent regulatory action to halt risk-adjustment payments should pose uncertainty for health insurers.


Mark Vickery

Top Research Reports for Mastercard, Gilead & Goldman Sachs

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Gilead (GILD) and Goldman Sachs (GS).


Sweta Jaiswal

Amazon Forays Into Pharmacy Business: Red Alert for Others?

Amazon's entry into the high-potential pharmaceutical industry deals a blow to share prices of major players.


Zacks Equity Research

LabCorp, Philips Tie Up to Advance in Digital Pathology

Through the latest collaboration, LabCorp (LH) aims at strengthening its hold inthe high potential digital pathology market.


Zacks Equity Research

UnitedHeathcare Arm Gets Charge of Kansas Medicaid Program

The State of Kansas picks UnitedHealth Group (UNH) arm for administering the statewide Medicaid Program.


Sanghamitra Saha

Want to Tap Merger Mania? Play Top-Ranked Health Care ETFs

What is driving Healthcare merger-mania and how to tap it with ETFs.


Zacks Equity Research

Rite Aid-Albertsons Deal: US SEC Sanctions Proxy Materials

Rite Aid (RAD) is moving closer to completing its previously announced merger with Albertsons. The company's shareholders are going to cast their votes regarding the deal on Aug 9.


Zacks Equity Research

Aetna Arm Secures Contract for its Kansas Medicaid Program

The State of Kansas awards Medicaid managed care contract to a subsidiary of Aetna (AET) for providing better health care to the Medicaid members.


Urmimala Biswas

Walgreens-GE Faceoff: How Impactful is it for Dow Investors?

The stock performance of Walgreens Boots (WBA) currently does not offer much conviction. Over the past year, shares show a decline of 17.9%.


Sapna Bagaria

Will Amazon's Entry Into Healthcare Disrupt the Market?

Appointment of a CEO for the healthcare alliance of Amazon, Berkshire Hathaway and JP Morgan marks invasion in the space.


Zacks Equity Research

Humana, Walgreens Team Up to Provide Better Senior Care

Humana (HUM) ties up with Walgreens to provide better primary care and other services to seniors of the Kansas City Community.


Zacks Equity Research

Anthem Boosts Integrated Care With Aspire Health Buyout

Anthem's (ANTM) acquisition of Aspire Health points to its increased efforts in comprehensive community-based palliative care space.